Cargando…

The Relationship between the Serum Oxytocin Levels, Disease Activity, the ADLs and the QOL in Patients with Rheumatoid Arthritis

OBJECTIVE: To investigate the factors associated with depression, including the serum oxytocin (OXT) levels, disease activity, activities of daily living (ADLs) and quality of life (QOL), and their effects on rheumatoid arthritis (RA). METHODS: This study included 42-RA-patients. We measured the fol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miwa, Yusuke, Furuya, Hidekazu, Yanai, Ryo, Kasama, Tsuyoshi, Sanada, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742387/ https://www.ncbi.nlm.nih.gov/pubmed/29021442 http://dx.doi.org/10.2169/internalmedicine.9191-17

Ejemplares similares

Predictor of the Simplified Disease Activity Index 50 (SDAI 50) at Month 3 of bDMARD Treatment in Patients with Long-Established Rheumatoid Arthritis
por: Miwa, Yusuke, et al.
Publicado: (2017)

Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission after Six Months of Non-tumor Necrosis Factor Biological Disease-Modifying Antirheumatic Drugs (DMARDs) Treatment
por: Miwa, Yusuke, et al.
Publicado: (2017)

Serum anticyclic citrullinated protein antibody titers are correlated with the response to biological agents in patients with rheumatoid arthritis
por: Takahashi, Ryo, et al.
Publicado: (2014)

Effect of TNF antagonists on the productivity of daily work of patients with rheumatoid arthritis
por: Furuya, Hidekazu, et al.
Publicado: (2013)

Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission with Six Months of Biological DMARDs Treatment
por: Miwa, Yusuke, et al.
Publicado: (2017)

Sex Differences in the Effects of a Biological Drug for Rheumatoid Arthritis on Depressive State
por: Tokunaga, Takahiro, et al.
Publicado: (2015)

Reduction of Serum ADAM17 Level Accompanied with Decreased Cytokines after Abatacept Therapy in Patients with Rheumatoid Arthritis
por: Umemura, Masayu, et al.
Publicado: (2014)

ADAM-17 is expressed on rheumatoid arthritis fibroblast-like synoviocytes and regulates proinflammatory mediator expression and monocyte adhesion
por: Ishii, Sho, et al.
Publicado: (2018)

Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis
por: Isozaki, Takeo, et al.
Publicado: (2010)

Involvement of CX3CL1/CX3CR1 axis in etanercept therapy for patients with active rheumatoid arthritis
por: Sato, Michihito, et al.
Publicado: (2011)

A Case of Rheumatoid Arthritis with Bucillamine-Induced Yellow Nail Syndrome Initially Manifesting as Pulmonary Disease
por: Isozaki, Takeo, et al.
Publicado: (2010)

Total Talar Replacement for Idiopathic Osteonecrosis of the Talus: Investigation of Clinical Outcomes, Pain, ADL, QOL
por: Ouchi, Kazuo, et al.
Publicado: (2023)

A novel mechanism for the regulation of IFN-γ inducible protein-10 expression in rheumatoid arthritis
por: Hanaoka, Ryosuke, et al.
Publicado: (2003)

Increased serum levels of macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis
por: Kanemitsu, Hirohito, et al.
Publicado: (2009)

Randomised study of PF-06410293, an adalimumab (ADL) biosimilar, compared with reference ADL for the treatment of active rheumatoid arthritis: results from weeks 26–52, including a treatment switch from reference ADL to PF-06410293
por: Fleischmann, Roy M, et al.
Publicado: (2021)

Impact of the Serum Level of Albumin and Self-Assessed Chewing Ability on Mortality, QOL, and ADLs for Community-Dwelling Older Adults at the Age of 85: A 15 Year Follow up Study
por: Nomura, Yoshiaki, et al.
Publicado: (2020)

Eotaxin-1/CCL11 is involved in cell migration in rheumatoid arthritis
por: Wakabayashi, Kuninobu, et al.
Publicado: (2021)

Recent advances in ADL, CutLang and adl2tnm
por: Unel, Gokhan
Publicado: (2021)

Application of Exploratory Factor Analysis and Item Response Theory to Validate NHANES ADL Scale in Patients Reporting Rheumatoid Arthritis
por: Sakharkar, Prashant, et al.
Publicado: (2022)

Peficitinib Inhibits the Chemotactic Activity of Monocytes via Proinflammatory Cytokine Production in Rheumatoid Arthritis Fibroblast-Like Synoviocytes
por: Ikari, Yuzo, et al.
Publicado: (2019)

Adherence to methotrexate and associated factors considering social desirability in patients with rheumatoid arthritis: a multicenter cross-sectional study
por: Yajima, Nobuyuki, et al.
Publicado: (2022)

A Disintegrin and Metalloprotease 15 is Expressed on Rheumatoid Arthritis Synovial Tissue Endothelial Cells and may Mediate Angiogenesis
por: Nishimi, Shinichiro, et al.
Publicado: (2019)

The efficacy of osteoporotic treatment in patients with new spinal vertebral compression fracture pain, ADL, QOL, bone metabolism and fracture-healing - In comparison with weekly teriparatide with bisphosphonate
por: Shigenobu, Keiichi, et al.
Publicado: (2019)

The Relationship Between Serum Angiogenic Factor Levels and Disease Activity in Rheumatoid Arthritis
por: ASLANALP, Zahide, et al.
Publicado: (2020)

Relationship Between Serum Vitamin D Level and Disease Severity in Rheumatoid Arthritis
por: Soltani Bajestani, Farhang, et al.
Publicado: (2023)

DOES TRUST IN SOCIAL SECURITY INHIBIT ACCEPTANCE OF ASSISTIVE TECHNOLOGY FOR ADL HELP?
por: Wakui, Tomoko, et al.
Publicado: (2022)

Synergistic induction of CX3CL1 by TNF alpha and IFN gamma in osteoblasts from rheumatoid arthritis: involvement of NF-kappa B and STAT-1 signaling pathways
por: Isozaki, Takeo, et al.
Publicado: (2008)

Relationship between balance function and QOL in cancer survivors and healthy subjects
por: Morishita, Shinichiro, et al.
Publicado: (2021)

Serum catestatin levels in patients with rheumatoid arthritis
por: Simac, Petra, et al.
Publicado: (2022)

Serum Adropin Levels in Patients with Rheumatoid Arthritis
por: Simac, Petra, et al.
Publicado: (2022)

Increased Serum Levels of Oxytocin in ‘Treatment Resistant Depression in Adolescents (TRDIA)’ Group
por: Sasaki, Tsuyoshi, et al.
Publicado: (2016)

Treatment with SDZ-ADL, an Adalimumab Biosimilar, in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis: Results of Patient-Reported Outcome Measures from Two Phase III Studies (ADMYRA and ADACCESS)
por: Blauvelt, Andrew, et al.
Publicado: (2021)

Relationship between VEGF Gene Polymorphisms and Serum VEGF Protein Levels in Patients with Rheumatoid Arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2016)

Serum hepcidin level and rheumatoid arthritis disease activity
por: Sahebari, Maryam, et al.
Publicado: (2019)

Testing Activities of Daily Living (ADL) in Patients with Age-Related Macular Degeneration Undergoing Cataract Surgery: Lessons Learned from the Past and Development of a New Quality of Life (QOL) Test
por: Borkenstein, Andreas F, et al.
Publicado: (2022)

Prediction for doubly charged Higgs using ADL
por: Ohrnberg, Ronja
Publicado: (2022)

FuncADL: Functional Analysis Description Language
por: Proffitt, Mason
Publicado: (2021)

EDUCATION AND PERCEIVED FUTURE NEED FOR ADL HELP
por: Finan, Julia
Publicado: (2022)

Relationship between rheumatoid arthritis and locomotive syndrome: validation of the 25-question Geriatric Locomotive Function Scale in patients with rheumatoid arthritis
por: Sobue, Yasumori, et al.
Publicado: (2019)

A GC polymorphism associated with serum 25-hydroxyvitamin D level is a risk factor for hip fracture in Japanese patients with rheumatoid arthritis: 10-year follow-up of the Institute of Rheumatology, Rheumatoid Arthritis cohort study
por: Yoshida, Shinji, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bl8r7h7cp4shc9speibts1hae9